show help

Das K

Author page

This page provides a summary of the entries in Polbase associated with this author.

The publication history graph presents the number of publications in Polbase by this author over time.

The polymerase chart indicates which polymerases this author has published on.

Polbase automatically discovers many polymerase papers as they are published. Some relevant papers are not included because the algorithm is designed to reduce background. Please contribute to polbase by adding your missing DNA polymerase papers.

Help icons:

The show help symbol in the upper-right corner of the page links to this help text. The question mark icon is used everywhere to indicate that help is available.

Missing references?

Publications:

Title Authors Year Journal
On the detection of multiple-binding modes of ligands to proteins, from biological, structural, and modeling data. Das K Journal of computer-aided molecular design
Molecular dynamics study of HIV-1 RT-DNA-Nevirapine complexes explains NNRTI inhibition, and resistance by connection mutations. Das K 2013 Proteins
Extension into the entrance channel of HIV-1 reverse transcriptase-Crystallography and enhanced solubility. Das K 2013 Bioorganic & medicinal chemistry letters
HIV-1 reverse transcriptase and antiviral drug resistance. Part 2. Das K 2013 Current opinion in virology
Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening. Das K 2013 Journal of medicinal chemistry
Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase. Das K 2013 Nature chemistry
HIV-1 reverse transcriptase and antiviral drug resistance. Part 1. Das K 2013 Current opinion in virology
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. Das K 2012 Retrovirology
HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism. Das K 2012 Nature structural & molecular biology
Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket. Das K 2011 Journal of medicinal chemistry
Structural basis of HIV-1 resistance to AZT by excision. Das K 2010 Nature structural & molecular biology
Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. Das K 2009 The Journal of biological chemistry
Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. Das K 2009 Journal of molecular biology
Conformational landscape of the human immunodeficiency virus type 1 reverse transcriptase non-nucleoside inhibitor binding pocket: lessons for inhibitor design from a cluster analysis of many crystal structures. Das K 2009 Journal of medicinal chemistry
Mutations in the thumb allow human immunodeficiency virus type 1 reverse transcriptase to be cleaved by protease in virions. Das K 2009 Journal of virology
Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site. Das K 2009 Structure (London, England : 1993)
Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase. Das K 2009 J Med Chem
Two-dimensional infrared spectra reveal relaxation of the nonnucleoside inhibitor TMC278 complexed with HIV-1 reverse transcriptase. Das K 2008 Proceedings of the National Academy of Sciences of the United States of America
Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design. Das K 2008 Nucleic acids research
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations. Das K 2008 Proceedings of the National Academy of Sciences of the United States of America
Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097. Das K 2007 Journal of molecular biology
Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme. Das K 2007 Journal of medicinal chemistry
Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. Das K 2005 Progress in biophysics and molecular biology
4-Benzyl and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones: in vitro evaluation of new C-3-amino-substituted and C-5,6-alkyl-substituted analogues against clinically important HIV mutant strains. Das K 2005 Journal of medicinal chemistry
Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity. Das K 2005 Journal of medicinal chemistry
Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1. Das K 2005 Journal of medicinal chemistry
In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). Das K 2005 J Med Chem
Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. Das K 2005 J Med Chem
Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains. Das K 2005 J Med Chem
Correlations between factors determining the pharmacokinetics and antiviral activity of HIV-1 non-nucleoside reverse transcriptase inhibitors of the diaryltriazine and diarylpyrimidine classes of compounds. Das K 2004 Drugs in R&D
Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. Das K 2004 J Med Chem
Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases. Das K 2004 Current opinion in structural biology
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. Das K 2003 Journal of virology
Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA. Das K 2002 The EMBO journal
Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. Das K 2001 The EMBO journal
HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors. Das K 2001 Antiviral therapy
Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). Das K 2001 J Virol
The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance. Das K 2001 Journal of molecular biology
Evolution of anti-HIV drug candidates. Part 2: Diaryltriazine (DATA) analogues. Das K 2001 Bioorganic & medicinal chemistry letters
Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. Das K 2001 Bioorganic & medicinal chemistry letters
Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids. Das K 1999 Proceedings of the National Academy of Sciences of the United States of America
Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site. Das K 1999 Chemistry & biology
Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance. Das K 1998 Journal of molecular biology
Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. Das K 1998 Journal of molecular biology
Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop. Das K 1997 Journal of virology
Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. Das K 1996 Journal of molecular biology
Targeting HIV reverse transcriptase for anti-AIDS drug design: structural and biological considerations for chemotherapeutic strategies. Das K 1996 Drug design and discovery
Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms. Das K 1996 Structure (London, England : 1993)
Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution. Das K 1995 Structure (London, England : 1993)
Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors. Das K 1995 Nat Struct Biol
Stimulation of DNA chain initiation by a protein factor (NPF-1) from rat liver of different ages. Das K 1989 Progress in clinical and biological research

Version:20241218

Using Polbase tables:

Sorting:

Tables may be sorted by clicking on any of the column titles. A second click reverses the sort order. <Ctrl> + click on the column titles to sort by more than one column (e.g. family then name).

Filtering:

It is also possible to filter the table by typing into the search box above the table. This will instantly hide lines from the table that do not contain your search text.